Multiple Sclerosis Clinical Trials in Phoenix

Showing 81-100 of 268 trials

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

NCT04602390

A safety study of ANK-700 in patients with relapsing remitting multiple sclerosis. The study has two parts: Part A - first in human study in which patients receive a single dose of ANK-700 Part B - patients will receive three doses of either ANK-700 or placebo

Multiple Sclerosis (MS)Relapsing Remitting Multiple Sclerosis

Anokion SA34 participantsStarted Nov 2020

Cullman, Alabama, United States • Phoenix, Arizona, United States • Aurora, Colorado, United States +12 more locations

TERMINATED< 1 mile

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

NCT05978531

This is an open-label, multicenter, observational study of the adherence of patients with relapsing-remitting multiple sclerosis (RRMS) prescribed Bafiertam (monomethyl fumarate) as their treatment.

Relapsing Remitting Multiple Sclerosis

Banner Life Sciences LLC25 participantsStarted Aug 2023

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +7 more locations

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice

Multiple Sclerosis Trials in Other Cities

The WEB-IT Clinical Study

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

ProVIDE II Bridging Study

Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Advancing Understanding of Transportation Options

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

A Study of PF-07260437 in Advanced or Metastatic Solid Tumors

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)

Other Conditions in Phoenix